|
USP39 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.226100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.882110E-02 |
| Normal-vs-Stage2 |
3.428800E-01 |
| Normal-vs-Stage3 |
4.127600E-01 |
| Normal-vs-Stage4 |
4.496300E-02 |
| Stage1-vs-Stage2 |
4.813000E-01 |
| Stage1-vs-Stage3 |
1.330600E-01 |
| Stage1-vs-Stage4 |
9.139400E-01 |
| Stage2-vs-Stage3 |
7.329000E-01 |
| Stage2-vs-Stage4 |
5.151000E-01 |
| Stage3-vs-Stage4 |
2.266600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.202400E-02 |
| Normal-vs-AfricanAmerican |
9.548000E-02 |
| Normal-vs-Asian |
1.013150E-01 |
| Caucasian-vs-AfricanAmerican |
3.688400E-01 |
| Caucasian-vs-Asian |
8.448600E-01 |
| AfricanAmerican-vs-Asian |
5.173200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.137440E-01 |
| Normal-vs-Female |
3.271700E-02 |
| Male-vs-Female |
8.228800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.677590E-02 |
| Normal-vs-Age(41-60Yrs) |
1.204160E-01 |
| Normal-vs-Age(61-80Yrs) |
1.374580E-01 |
| Normal-vs-Age(81-100Yrs) |
6.993200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.698800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.825800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.227200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.273000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.708000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.126200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.646750E-01 |
| Classical-VS-Follicular |
4.557900E-02 |
| Classical-VS-Other |
3.894600E-01 |
| Classical-VS-Normal |
7.176700E-03 |
| Tall-VS-Follicular |
9.062000E-01 |
| Tall-VS-Other |
8.947800E-01 |
| Tall-VS-Normal |
4.947800E-01 |
| Follicular-VS-Other |
9.561200E-01 |
| Follicular-VS-Normal |
5.338800E-01 |
| Other-VS-Normal |
8.106000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.019220E-01 |
| Normal-vs-N1 |
9.250600E-01 |
| N0-vs-N1 |
1.523360E-01 |
|
|
